Allen Gruenberg

Title: Allen Gruenberg: Innovator in Veterinary Vaccines

Introduction

Allen Gruenberg is a notable inventor based in Wellington, New Zealand. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for canine diseases. His work has led to the creation of innovative solutions that enhance the health and well-being of dogs.

Latest Patents

Allen Gruenberg holds 2 patents related to attenuated canine parvovirus vaccines. His first patent is directed to attenuated canine parvovirus (CPV) strains, which may be used as a veterinary vaccine against CPV disease. This invention includes a virus stock generated from a genomic DNA clone of the attenuated CPV strain, which is capable of conferring protective immunity to dogs against virulent CPV. The methods for producing an attenuated CPV virus from a cloned CPV genome are also detailed in this patent. His second patent similarly focuses on a novel attenuated CPV strain that serves as a veterinary vaccine against CPV disease, further emphasizing the importance of his research in this area.

Career Highlights

Allen Gruenberg is affiliated with Cornell University, where he continues to advance his research in veterinary vaccines. His work has been instrumental in developing effective solutions to combat canine diseases, showcasing his dedication to improving animal health.

Collaborations

Throughout his career, Allen has collaborated with esteemed colleagues such as Colin Parrish and Leland E Carmichael. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Allen Gruenberg's contributions to veterinary medicine through his innovative patents on canine parvovirus vaccines highlight his commitment to animal health. His work not only benefits dogs but also sets a precedent for future research in veterinary vaccines.